Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency
US-9828435-B2 · Nov 28, 2017 · US
This page is not indexed by search engines while we improve data quality.
Vaccinex Inc patents in 2017
Vaccinex Inc was listed as an assignee on 14 patent publications in 2017.
| Metric | Value |
|---|---|
| Company | Vaccinex Inc |
| Year | 2017 |
| Patents | 14 |
Patents
Representative publications for Vaccinex Inc in 2017.
Use of semaphorin-4d inhibitory molecules in combination with an immune modulating therapy to inhibit tumor growth and metastases
US-2017335008-A1 · Nov 23, 2017 · US
Targeted CD1d molecules
US-9809654-B2 · Nov 7, 2017 · US
MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES
US-2017312356-A1 · Nov 2, 2017 · US
Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit
US-2017306318-A1 · Oct 26, 2017 · US
Top CPC classifications
Most common classification codes for Vaccinex Inc in 2017.
| CPC | Patents |
|---|---|
| C07K16/2803 | 10 |
| C07K2317/56 | 9 |
| A61K2039/505 | 8 |
| A61P35/00 | 8 |
| A61P43/00 | 8 |
Related pages
Navigate to parent entity pages.